KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Thermo Fisher Scientific (TMO) Other Non-Current Liabilities (2016 - 2025)

Historic Other Non-Current Liabilities for Thermo Fisher Scientific (TMO) over the last 17 years, with Q3 2025 value amounting to $4.3 billion.

  • Thermo Fisher Scientific's Other Non-Current Liabilities fell 149.67% to $4.3 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $4.3 billion, marking a year-over-year decrease of 149.67%. This contributed to the annual value of $4.0 billion for FY2024, which is 1406.72% down from last year.
  • As of Q3 2025, Thermo Fisher Scientific's Other Non-Current Liabilities stood at $4.3 billion, which was down 149.67% from $4.3 billion recorded in Q2 2025.
  • Thermo Fisher Scientific's 5-year Other Non-Current Liabilities high stood at $4.7 billion for Q2 2022, and its period low was $3.4 billion during Q2 2021.
  • Over the past 5 years, Thermo Fisher Scientific's median Other Non-Current Liabilities value was $4.3 billion (recorded in 2025), while the average stood at $4.2 billion.
  • Per our database at Business Quant, Thermo Fisher Scientific's Other Non-Current Liabilities soared by 3914.08% in 2022 and then tumbled by 1406.72% in 2024.
  • Over the past 5 years, Thermo Fisher Scientific's Other Non-Current Liabilities (Quarter) stood at $4.5 billion in 2021, then dropped by 6.65% to $4.2 billion in 2022, then rose by 9.53% to $4.6 billion in 2023, then fell by 14.07% to $4.0 billion in 2024, then rose by 7.24% to $4.3 billion in 2025.
  • Its last three reported values are $4.3 billion in Q3 2025, $4.3 billion for Q2 2025, and $4.0 billion during Q1 2025.